Document is current
Any future updates will be listed below
-
Authors
Avendano, Daly
Marino, Maria Adele
Bosques-Palomo, Beatriz A.
Dávila-Zablah, Yesika
Zapata, Pedro
Avalos-Montes, Pablo J.
Armengol-García, Cecilio
Sofia, Carmelo
Garza-Montemayor, Margarita
Pinker, Katja
Cardona-Huerta, Servando https://orcid.org/0000-0001-8595-4177
Tamez-Peña, José
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
CONAHCYT
Tecnologico de Monterrey
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 1 September 2024
First Online: 10 October 2024
Declarations
:
: This retrospective study received approval from the local institutional ethical committee (protocol number: P000542-MIRAI-MODIFICADO-CEIC-CR002). The local institutional ethical committee also provided a waiver for written informed consent.
: Not applicable.
: The authors of this manuscript declare relationships with the following companies: S.C.-H. declares being speaker for Roche and AstraZeneca. K.P. declares being part of speakers bureaus for the European Society of Breast Imaging (EUSOBI) (active), Bayer (ended), Siemens Healthineers (ended), DKD 2019 (ended), Olea Medical (ended), and Roche (ended); consulting for Genentech, Merantix Healthcare, AURA Health Technologies. Guerbet, and Bayer. The remaining authors declare that they have no competing interests.
